Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative (Q41444798)

30 September 2017

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative (English)

1 reference

30 September 2017

6

1 reference

30 September 2017

11

1 reference

30 September 2017

13

Jean Wactawski-Wende

1 reference

30 September 2017

John D Potter

5

0 references

JoAnn E. Manson

series ordinal

9

object named as

JoAnn E Manson

1 reference

30 September 2017

4

Ulrike Peters

1 reference

30 September 2017

10

Mara Z Vitolins

1 reference

30 September 2017

8

Dorothy S Lane

1 reference

30 September 2017

12

Jean Y Tang

1 reference

30 September 2017

2

Jingmin Liu

1 reference

30 September 2017

1

Theodore M Brasky

1 reference

30 September 2017

Emily White

3

1 reference

30 September 2017

Christina S Baik

series ordinal

7

1 reference

30 September 2017

language of work or name

English

0 references

publication date

20 March 2014

1 reference

International Journal of Cancer

30 September 2017

1 reference

30 September 2017

135

1 reference

30 September 2017

8

1 reference

30 September 2017

1869-1883

1 reference

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin and cancer risk: a quantitative review to 2011.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin use and breast cancer risk: a meta-analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin use and risk for lung cancer: a meta-analysis.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Analgesic use and sex steroid hormone concentrations in postmenopausal women

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

The role of COX-2 in intestinal inflammation and colorectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin use and survival after diagnosis of colorectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

The association between aspirin use and the incidence of colorectal cancer in women

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

The Women's Health Initiative recruitment methods and results

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5592086

Design of the Women’s Health Initiative Clinical Trial and Observational Study

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002/IJC.28823

Implementation of the women's health initiative study design

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002/IJC.28823

The women's health initiative calcium–vitamin D trial: overview and baseline characteristics of participants

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002/IJC.28823

Outcomes ascertainment and adjudication methods in the women's health initiative

21 January 2018

1 reference

12 December 2020

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants

1 reference

12 December 2020

Association between non-steroidal anti-inflammatory drug use and melanoma risk: a meta-analysis of 13 studies

1 reference

12 December 2020

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

12 December 2020

The women's health initiative dietary modification trial: overview and baseline characteristics of participants

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.28823

1 reference

30 September 2017

1 reference

30 September 2017

PubMed publication ID

24599876

1 reference